These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2910524)

  • 1. Neuroendocrine dysdifferentiation and bombesin production in carcinogen-induced hepatocellular rat tumours.
    Seglen PO; Skomedal H; Saeter G; Schwarze PE; Nesland JM
    Carcinogenesis; 1989 Jan; 10(1):21-5. PubMed ID: 2910524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical markers of small cell carcinoma and related neuroendocrine tumours of the lung.
    Addis BJ; Hamid Q; Ibrahim NB; Fahey M; Bloom SR; Polak JM
    J Pathol; 1987 Oct; 153(2):137-50. PubMed ID: 2826741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stable phenotypic expression of glutathione S-transferase placental type and unstable phenotypic expression of gamma-glutamyltransferase in rat liver preneoplastic and neoplastic lesions.
    Tatematsu M; Mera Y; Inoue T; Satoh K; Sato K; Ito N
    Carcinogenesis; 1988 Feb; 9(2):215-20. PubMed ID: 2892592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selected markers (chromogranin A, neuron-specific enolase, synaptophysin, protein gene product 9.5) in diagnosis and prognosis of neuroendocrine pulmonary tumours.
    Kasprzak A; Zabel M; Biczysko W
    Pol J Pathol; 2007; 58(1):23-33. PubMed ID: 17585539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'Neuroendocrine' differentiation in primary neoplasms of the liver.
    Wang JH; Dhillon AP; Sankey EA; Wightman AK; Lewin JF; Scheuer PJ
    J Pathol; 1991 Jan; 163(1):61-7. PubMed ID: 1848288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-alpha in carcinogen-induced F344 rat hepatic foci.
    Steinmetz KL; Klaunig JE
    Toxicol Appl Pharmacol; 1996 Sep; 140(1):131-45. PubMed ID: 8806879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell proliferation induced by triiodothyronine in rat liver is associated with nodule regression and reduction of hepatocellular carcinomas.
    Ledda-Columbano GM; Perra A; Loi R; Shinozuka H; Columbano A
    Cancer Res; 2000 Feb; 60(3):603-9. PubMed ID: 10676643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-parenchymal liver cells support the growth advantage in the first stages of hepatocarcinogenesis.
    Drucker C; Parzefall W; Teufelhofer O; Grusch M; Ellinger A; Schulte-Hermann R; Grasl-Kraupp B
    Carcinogenesis; 2006 Jan; 27(1):152-61. PubMed ID: 16081514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunocytochemical evidence for neuroendocrine differentiation in human breast carcinomas.
    Monaghan P; Roberts JD
    J Pathol; 1985 Dec; 147(4):281-9. PubMed ID: 3003310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrine differentiation of extra-pulmonary small cell carcinoma demonstrated by immunohistochemistry using antibodies to PGP 9.5, neuron-specific enolase and the C-flanking peptide of human pro-bombesin.
    Springall DR; Ibrahim NB; Rode J; Sharpe MS; Bloom SR; Polak JM
    J Pathol; 1986 Nov; 150(3):151-62. PubMed ID: 3027289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroendocrine differentiation in colorectal carcinomas.
    Syversen U; Halvorsen T; Mårvik R; Waldum HL
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):667-74. PubMed ID: 8590163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurone specific enolase immunostaining in the diagnosis of breast carcinomas with neuroendocrine differentiation. Its usefulness and limitations.
    Nesland JM; Holm R; Johannessen JV; Gould VE
    J Pathol; 1986 Jan; 148(1):35-43. PubMed ID: 3003312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of carcinogens on the induction of placental glutathione S-transferase-positive liver nodules in a short-term assay and of hepatocellular carcinomas in a long-term assay.
    Ogiso T; Tatematsu M; Tamano S; Tsuda H; Ito N
    Toxicol Pathol; 1985; 13(4):257-65. PubMed ID: 3834582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential analysis of chemically induced hepatoma development in rats by two dimensional electrophoresis.
    Wirth PJ; Benjamin T; Schwartz DM; Thorgeirsson SS
    Cancer Res; 1986 Jan; 46(1):400-13. PubMed ID: 3940206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of ErbB receptor proteins and TGF-alpha during diethylnitrosamine-induced hepatocarcinogenesis in the rat liver.
    Lee TY; Kim KT; Han SY
    Korean J Hepatol; 2007 Mar; 13(1):70-80. PubMed ID: 17380077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PGP 9.5, a new marker for human neuroendocrine tumours.
    Rode J; Dhillon AP; Doran JF; Jackson P; Thompson RJ
    Histopathology; 1985 Feb; 9(2):147-58. PubMed ID: 2580771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The polyploidizing growth pattern of normal rat liver is replaced by divisional, diploid growth in hepatocellular nodules and carcinomas.
    Saeter G; Schwarze PE; Nesland JM; Juul N; Pettersen EO; Seglen PO
    Carcinogenesis; 1988 Jun; 9(6):939-45. PubMed ID: 3370757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-erbB-2 protein and neuroendocrine expression in breast carcinomas.
    Nesland JM; Ottestad L; Heikilla R; Holm R; Tveit K; Børresen AL
    Anticancer Res; 1991; 11(1):161-7. PubMed ID: 1673329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of neuroendocrine markers (neuronspecific enolase, synaptophysin and bombesin) in carcinoma of the lung.
    Kayser K; Schmid W; Ebert W; Wiedenmann B
    Pathol Res Pract; 1988 Aug; 183(4):412-7. PubMed ID: 3141909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporine enhances the growth of carcinogen-induced enzyme-altered foci in rat liver.
    Yabu K; Warty VS; Shinozuka H
    Hepatology; 1991 Feb; 13(2):304-9. PubMed ID: 1995440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.